Fiagon AG Medical Technologies — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Total funding raised: $10M

Overview

Fiagon is a pioneer in electromagnetic surgical navigation, originating from a doctoral project in Germany. The company's core technology focuses on reducing electromagnetic distortion and system footprint in the OR while providing intuitive, integrated solutions for surgeons. Having gained FDA clearance in 2014, Fiagon has expanded globally into the US, Chinese, and European markets, establishing itself as a technology leader in its niche. The company underwent a significant ownership change in 2022 when its assets were acquired by Hemostasis, LLC.

ENT (Otolaryngology)Neurosurgery

Technology Platform

Proprietary electromagnetic (EM) surgical navigation platform featuring miniaturized sensors, advanced distortion-correction algorithms, and a compact system design for real-time instrument tip tracking in ENT and neurosurgery.

Funding History

1

Total raised:$10M

Series A$10MUndisclosedMar 15, 2018

Opportunities

Expansion into high-growth outpatient and in-office surgical centers with procedures like Navigated Sinuplasty presents a significant new market segment.

Leveraging the financial backing and commercial infrastructure of Hemostasis/GTCR can accelerate market penetration in the competitive US neurosurgery and ENT landscapes.

Further integration with intraoperative imaging and potential expansion into adjacent surgical specialties (e.g., spine, orthopedics) offer long-term platform extension opportunities.

Risk Factors

Intense competition from larger, well-capitalized medical device giants with broader portfolios and established sales channels poses a constant threat.

Technological obsolescence is a key risk if competitors advance optical or hybrid navigation systems that match or exceed Fiagon's EM precision and usability.

Execution risk under new ownership, including potential integration challenges and cultural shifts, could disrupt commercial momentum and R&D focus.

Competitive Landscape

Fiagon competes in the surgical navigation market against major players like Medtronic (StealthStation), Stryker (NAV3i), and Brainlab, which dominate with optical and hybrid tracking systems. Fiagon's differentiation lies in its compact, electromagnetic platform designed for minimal OR footprint and high precision with tip-based tracking. It occupies a strong niche, particularly in ENT, but must continuously innovate to defend against competitors' extensive R&D resources and deep hospital relationships.

More companies in Diagnostics & Precision Medicine →More companies in Germany →